腔内治疗急性下肢缺血的研究进展  

Research progress of endovascular treatment of acute lower limb ischemia

作　　者：战明威 张晨光 王瀚锐[1] 金松[1] Zhan Mingwei;Zhang Chenguang;Wang Hanrui;Jin Song(Department of Vascular Surgery,the First Affiliated Hospital of Jiamusi University,Jiamusi 154002,Heilongjiang,China)

机构地区：[1]佳木斯大学附属第一医院血管外科,黑龙江佳木斯154002

出　　处：《血管与腔内血管外科杂志》2020年第6期546-551,共6页Journal of Vascular and Endovascular Surgery

摘　　要：急性下肢缺血(ALLI)是指近期(持续时间<14 d)突发肢体血液灌注减少,患者常出现疼痛、无脉、苍白、皮温降低、麻木和运动障碍等症状。目前,ALLI是卫生系统的主要负担也是造成截肢常见原因,因此选择一种适合的血运重建治疗策略,是保留肢体和挽救患者生命的关键。随着溶栓治疗和导管技术的进步,腔内治疗已经成为ALLI的一线治疗方法,本研究通过对ALLI的病因、诊断及腔内治疗等方面进行综述,以期为临床治疗提供依据。Acute lower limb ischemia(ALLI)refers to the sudden decrease of limb blood perfusion in the short term(lasting less than 14 days).Patients often have symptoms of pain,pulseless,pallor,decreased skin temperature,numbness and dyskinesia.At present,ALLI is the main burden of the health system and a common cause of amputation.Therefore,choosing a suitable revascularization treatment strategy is the key to preserve the limbs and save the lives of patients.With the progress of thrombolytic therapy and catheter technology,endovascular therapy has become the first-line treatment of ALLI.This study reviewed the etiology,diagnosis and endovascular treatment of ALLI,in order to provide the basis for clinical treatment in the future.

关 键 词：急性下肢缺血 腔内治疗 导管溶栓术 经皮机械血栓切除术 

分 类 号：R543.5[医药卫生—心血管疾病]